Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 20-Aug-24 6:27 PM View:  | Atara Biotherapeutics, Inc. (ATRA) | 16-Aug-24 | Sale | 1,158 | $6.63 | $7,676.75 | (4%) 27.98K to 26.83K | |
| 20-May-24 8:33 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 16-May-24 | Sale | 32,401 | $0.62 | $19,991.40 | (4%) 727.52K to 695.12K | |
| 06-Mar-24 10:00 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 04-Mar-24 | Sale | 10,044 | $0.72 | $7,231.68 | (1%) 737.57K to 727.52K | |
| 09-Jan-24 4:40 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 08-Jan-24 | Grant | 475,000 | -- | -- | 181% 262.56K to 737.57K | |
| 18-Aug-23 6:25 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 16-Aug-23 | Sale | 8,672 | $1.65 | $14,329.80 | (3%) 274.06K to 265.39K | |
| 18-May-23 8:17 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 16-May-23 | Sale | 8,389 | $2.04 | $17,089.40 | (3%) 279.33K to 270.94K | |
| 06-Mar-23 6:48 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 02-Mar-23 | Sale (Planned) | 4,221 | $3.63 | $15,309.60 | (1%) 283.56K to 279.33K | |
| 03-Mar-23 5:15 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 01-Mar-23 | Grant | 155,375 | -- | -- | 121% 128.18K to 283.56K | |
| 18-Nov-22 8:13 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 16-Nov-22 | Sale (Planned) | 3,612 | $4.49 | $16,217.90 | (3%) 131.2K to 127.59K | |
| 18-Aug-22 6:21 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 16-Aug-22 | Sale (Planned) | 3,430 | $5.03 | $17,268.90 | (3%) 134.63K to 131.2K | |
| 19-May-22 5:20 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 17-May-22 | Sale (Planned) | 3,223 | $5.32 | $17,134.40 | (2%) 136.96K to 133.74K | |
| 03-Mar-22 7:02 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 01-Mar-22 | Grant | 51,814 | -- | -- | 59% 87.72K to 139.53K | |
| 03-Mar-22 7:02 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 01-Mar-22 | Sale (Planned) | 2,577 | $9.86 | $25,400.40 | (2%) 139.53K to 136.96K | |
| 18-Nov-21 5:53 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 16-Nov-21 | Market Sale (Planned) | 2,124 | $17.12 | $36,356.30 | (2%) 89.66K to 87.54K | (4%) |
| 19-Aug-21 7:35 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 17-Aug-21 | Market Sale (Planned) | 2,080 | $12.53 | $26,066.60 | (2%) 91.74K to 89.66K | < 1% |
| 20-May-21 4:32 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 18-May-21 | Market Sale (Planned) | 5,681 | $14.55 | $82,658.60 | (6%) 97.42K to 91.74K | 4% |
| 03-Mar-21 5:16 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 01-Mar-21 | Grant | 41,756 | -- | -- | 75% 55.67K to 97.42K | |
| 21-Apr-20 4:17 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 20-Apr-20 | Grant | 55,000 | -- | -- | 100% 0 to 55.0K |